Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

4.57
-0.1750-3.69%
Volume:417.84K
Turnover:1.94M
Market Cap:516.12M
PE:-1.01
High:4.78
Open:4.69
Low:4.56
Close:4.74
52wk High:10.08
52wk Low:2.10
Shares:113.06M
Float Shares:94.15M
Volume Ratio:1.26
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5419
EPS(LYR):-5.0732
ROE:-66.97%
ROA:-0.78%
PB:1.35
PE(LYR):-0.90

Loading ...

Evolent Health to release first-quarter results, host conference call before market open

Reuters
·
Apr 08

Privia Health publishes 2025 annual report, revenue rises 22.3% to $2.12 billion

Reuters
·
Apr 02

Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress

GlobeNewswire
·
Mar 26

Evolent Health appoints Archie Mayani as chief product officer

Reuters
·
Mar 19

Evolent Announces Appointment of Archie Mayani as Chief Product Officer

THOMSON REUTERS
·
Mar 19

Evolent Health (EVH) Receives a Buy from J.P. Morgan

TIPRANKS
·
Mar 03

Evolent Health Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Mar 02

Evolent Health: Conservative 2026 Guidance Masks Attractive Valuation and Upside to EBITDA Targets

TIPRANKS
·
Mar 02

Evolent Health Charts Growth Amid 2026 Margin Squeeze

TIPRANKS
·
Mar 01

Evolent Health executives to present at Cowen Annual Healthcare Conference and Oppenheimer Healthcare MedTech and Services Conference

Reuters
·
Feb 27

Evolent Health (EVH) Gets a Buy from Stephens

TIPRANKS
·
Feb 26

Truist Cuts Price Target on Evolent Health to $6 From $10, Keeps Buy Rating

MT Newswires Live
·
Feb 26

Evolent Health Is Maintained at Buy by Truist Securities

Dow Jones
·
Feb 26

Evolent Health Q4 Loss Of US$3.84 Per Share Tests Bullish Margin Turnaround Narrative

Simply Wall St.
·
Feb 26

Evolent Health price target lowered to $6 from $10 at Truist

TIPRANKS
·
Feb 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evolent Health (EVH), Medtronic (MDT) and Cytokinetics (CYTK)

TIPRANKS
·
Feb 25

Evolent Health price target lowered to $4 from $9 at Canaccord

TIPRANKS
·
Feb 25

Evolent Health: Conservative Guidance and Elevated Reserves Set the Stage for 2026 Margin Upside and Support a Buy Rating

TIPRANKS
·
Feb 25

Evolent Health Cut to Sector Weight From Overweight by Keybanc

Dow Jones
·
Feb 25

KeyBanc Downgrades Evolent Health to Sector Weight From Overweight

MT Newswires Live
·
Feb 25